Pitfalls of anesthetic management with the Impella® 5.0 device: a case series
Abstract Background Impella® is an antegrade left ventricular assist device with a pump catheter in the left ventricle. We report three cases in which we experienced some pitfalls with circulatory management during Impella placement due to new-onset aortic insufficiency (AI) associated with device p...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-03-01
|
Series: | JA Clinical Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40981-020-00324-9 |
id |
doaj-f772aff2c5664f9ea411a57b19efe2d7 |
---|---|
record_format |
Article |
spelling |
doaj-f772aff2c5664f9ea411a57b19efe2d72021-04-02T11:48:17ZengSpringerOpenJA Clinical Reports2363-90242020-03-01611510.1186/s40981-020-00324-9Pitfalls of anesthetic management with the Impella® 5.0 device: a case seriesNaoshi Hotta0Akito Tsukinaga1Kenji Yoshitani2Yoshihiko Ohnishi3Department of Anesthesiology, National Cerebral and Cardiovascular CenterDepartment of Anesthesiology, National Cerebral and Cardiovascular CenterDepartment of Anesthesiology, National Cerebral and Cardiovascular CenterDepartment of Anesthesiology, National Cerebral and Cardiovascular CenterAbstract Background Impella® is an antegrade left ventricular assist device with a pump catheter in the left ventricle. We report three cases in which we experienced some pitfalls with circulatory management during Impella placement due to new-onset aortic insufficiency (AI) associated with device placement or the limited maximum flow rate. Case presentation Three patients developed new-onset AI due to Impella placement. In a patient, the total assisted flow rate was relatively low because of his large body size. In the other patients, in whom the Impella device was used in combination with percutaneous cardiopulmonary support or venoarterial extracorporeal membrane oxygenation (ECMELLA), total flow was maintained at a sufficient level. Conclusions New-onset of AI after Impella placement and its limited flow rate are considered to be pitfalls in circulatory management. Management with ECMELLA is considered to be effective during the acute phase when patients have decreased cardiac function.http://link.springer.com/article/10.1186/s40981-020-00324-9Percutaneous ventricular assist deviceAdvanced medical careHeart failure |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Naoshi Hotta Akito Tsukinaga Kenji Yoshitani Yoshihiko Ohnishi |
spellingShingle |
Naoshi Hotta Akito Tsukinaga Kenji Yoshitani Yoshihiko Ohnishi Pitfalls of anesthetic management with the Impella® 5.0 device: a case series JA Clinical Reports Percutaneous ventricular assist device Advanced medical care Heart failure |
author_facet |
Naoshi Hotta Akito Tsukinaga Kenji Yoshitani Yoshihiko Ohnishi |
author_sort |
Naoshi Hotta |
title |
Pitfalls of anesthetic management with the Impella® 5.0 device: a case series |
title_short |
Pitfalls of anesthetic management with the Impella® 5.0 device: a case series |
title_full |
Pitfalls of anesthetic management with the Impella® 5.0 device: a case series |
title_fullStr |
Pitfalls of anesthetic management with the Impella® 5.0 device: a case series |
title_full_unstemmed |
Pitfalls of anesthetic management with the Impella® 5.0 device: a case series |
title_sort |
pitfalls of anesthetic management with the impella® 5.0 device: a case series |
publisher |
SpringerOpen |
series |
JA Clinical Reports |
issn |
2363-9024 |
publishDate |
2020-03-01 |
description |
Abstract Background Impella® is an antegrade left ventricular assist device with a pump catheter in the left ventricle. We report three cases in which we experienced some pitfalls with circulatory management during Impella placement due to new-onset aortic insufficiency (AI) associated with device placement or the limited maximum flow rate. Case presentation Three patients developed new-onset AI due to Impella placement. In a patient, the total assisted flow rate was relatively low because of his large body size. In the other patients, in whom the Impella device was used in combination with percutaneous cardiopulmonary support or venoarterial extracorporeal membrane oxygenation (ECMELLA), total flow was maintained at a sufficient level. Conclusions New-onset of AI after Impella placement and its limited flow rate are considered to be pitfalls in circulatory management. Management with ECMELLA is considered to be effective during the acute phase when patients have decreased cardiac function. |
topic |
Percutaneous ventricular assist device Advanced medical care Heart failure |
url |
http://link.springer.com/article/10.1186/s40981-020-00324-9 |
work_keys_str_mv |
AT naoshihotta pitfallsofanestheticmanagementwiththeimpella50deviceacaseseries AT akitotsukinaga pitfallsofanestheticmanagementwiththeimpella50deviceacaseseries AT kenjiyoshitani pitfallsofanestheticmanagementwiththeimpella50deviceacaseseries AT yoshihikoohnishi pitfallsofanestheticmanagementwiththeimpella50deviceacaseseries |
_version_ |
1721571246618968064 |